Disclosed positions

Estimated from their latest filings — positions may have changed since

$273.3K

combined est. value

Stock	Shares	Price	Value	Weight	As of
ACRVAcrivon Therapeutics, Inc.	146,953	$1.86	$273.3K	100%	2026-05-18

ACRV

Acrivon Therapeutics, Inc.

$273.3K

146,953 sh

Activity

Open-market buy & sell volume

BuySell

Total +$17.2K bought

Most bought

ACRV

$17.2K

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 1sells 0

Stock	Transaction	Date	~6mo later
ACRVAcrivon Therapeutics, Inc.	Grant — · 72,981 sh	2026-05-18	—
ACRVAcrivon Therapeutics, Inc.	Tax $1.2K · 613 sh	2026-05-14	—
ACRVAcrivon Therapeutics, Inc.	Tax $1.2K · 723 sh	2026-02-14	—
ACRVAcrivon Therapeutics, Inc.	Buy $17.2K · 10,000 sh	2026-01-13	in progress
ACRVAcrivon Therapeutics, Inc.	Tax $1.4K · 613 sh	2025-11-14	—
ACRVAcrivon Therapeutics, Inc.	Tax $852.07 · 613 sh	2025-08-14	—

ACRVGrant

2026-05-18 · Acrivon Therapeutics, Inc.

72,981

—

ACRVTax

2026-05-14 · Acrivon Therapeutics, Inc.

$1.2K

—

ACRVTax

2026-02-14 · Acrivon Therapeutics, Inc.

$1.2K

—

ACRVBuy

2026-01-13 · Acrivon Therapeutics, Inc.

$17.2K

in progress

ACRVTax

2025-11-14 · Acrivon Therapeutics, Inc.

$1.4K

—

ACRVTax

2025-08-14 · Acrivon Therapeutics, Inc.

$852.07

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.